Omnitrope: Enhancing Growth in SGA Infants – Mechanism, Efficacy, and Safety
Reading Time: 2 minutes Introduction to Omnitrope Omnitrope is a recombinant human growth hormone (rhGH) that has been approved by the FDA for the treatment of growth failure in children, including those who are small for gestational age (SGA). This synthetic hormone replicates the natural growth hormone produced by the pituitary gland, which is essential for normal growth and development in children. For American males concerned about the growth and development of their SGA infants, understanding the role of Omnitrope can be crucial. Understanding Small for Gestational Age (SGA) Infants classified as SGA are born with a birth weight or length that is below...


